Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Behavioral Medicine
Published in: Annals of Behavioral Medicine 2/2012

01-10-2012 | Original Article

A Psychoeducational Intervention (SWEEP) for Depressed Women with Diabetes

Authors: Sue M. Penckofer, Ph.D., R.N., Carol Ferrans, Ph.D., R.N., Patricia Mumby, Ph.D., R.N., Mary Byrn, Ph.D., R.N., Mary Ann Emanuele, M.D., Patrick R. Harrison, M.A., Ramon A. Durazo-Arvizu, Ph.D., Patrick Lustman, Ph.D.

Published in: Annals of Behavioral Medicine | Issue 2/2012

Login to get access

Abstract

Background

Clinically significant depression is present in 25 % of individuals with type 2 diabetes, its risk being doubled in women.

Purpose

To examine the effectiveness of the Study of Women’s Emotions and Evaluation of a Psychoeducational (SWEEP), a group therapy for depression treatment based on cognitive behavioral therapy principles that was developed for women with type 2 diabetes was conducted.

Methods

Women with significantly elevated depression symptoms (Center for Epidemiologic Studies Depression Scale ≥16) were randomized to SWEEP (n = 38) or usual care (UC, n = 36).

Results

Multilevel modeling indicated that SWEEP was more effective than UC in reducing depression (mean difference of −15 vs. −7, p < .01), decreasing trait anxiety (mean difference of −15 vs. −5, p < .01), and improving anger expression (mean difference of −12 vs. −5, p < .05). Although SWEEP and UC had improvements in fasting glucose (mean difference of −24 vs. −1 mg/dl) and HbA1c (mean difference of −0.4 vs. −0.1 %), there were no statistically significant differences between groups.

Conclusions

SWEEP was more effective than UC for treating depressed women with type 2 diabetes. Addition of group therapy for depression meaningfully expands the armamentarium of evidence-based treatment options for women with diabetes.
Literature
1.
Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002; 25: 464–470.PubMedCrossRef
2.
Egede LE. Major depression in individuals with chronic medical disorders: Prevalence, correlates and association with health resource utilization, less productivity, and functional disability. Gen Hosp Psychiatry. 2007; 29: 409–416.PubMedCrossRef
3.
Lustman PJ, Clouse RE, Nix BD, et al. Sertraline for prevention of depression recurrence in diabetes mellitus. Arch Gen Psychiatry. 2006; 63: 521–529.PubMedCrossRef
4.
Lustman PJ, Williams, MM, Sayuk GS, Nix BD, Clouse RE. Factors influencing glycemic control in type 2 diabetes during acute-and maintenance-phase treatment of major depressive disorder with bupropion. Diabetes Care. 2007; 30: 459–466.PubMedCrossRef
5.
Williams MM, Clouse RE, Nix BD, et al. Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes. Diabetes Care. 2007; 30: 801–806.PubMedCrossRef
6.
Lustman, PJ, Griffith, LS, Clouse, RE, et al. Effects of nortriptyline on depression and glycemic control in diabetes: Results of a double-blind, placebo-controlled trial. Psychosom Med. 1997; 59: 241–250.PubMed
7.
Lisi DM. Diabetes and the psychiatric patient. US Pharmacist. 2010; 35: 62–79.
8.
Amiel JM, Manguarian CV, Ganguli R, Newcomer JS. Addressing cardiometabolic risk during treatment with anti-psychotic medications. Curr Opin Psychiatry. 2008; 21(6): 613–618.PubMedCrossRef
9.
Morrato EH, Newcomer JS, Kamat S, Baser O, Harnett J, Cuffel B. Metabolic screening after the American Diabetes Association’s consensus statement on antipsychotic drugs and diabetes. Diabetes Care. 2009; 32(6): 1037–1042.PubMedCrossRef
10.
Derijks HJ, Meyboom RH, Heerdink ER, et al. The association between antidepressant use and the disturbance in glucose homeostasis: Evidence from spontaneous reports. Eur J Clin Pharmacol. 2008; 64(5): 531–538PubMedCrossRef
11.
Bai YM, Lin CC, Chen JY, Chen TT, Su TP, Chou P. Association of weight gain and metabolic syndrome in patients taking clozapine: An 8-year cohort. J Clin Psychiatry. 2011; 72(6): 751–756.PubMedCrossRef
12.
Torrent C, Amann B, Sanchez-Moreno J, et al. Weight gain in bipolar disorder: Pharmacological treatment as a contributing factor. Acta Psychiatr Scand. 2008; 118: 4–18.PubMedCrossRef
13.
Schwartz TL, Nihalani N, Virk S, Jindal S, Chilton M. Psychiatric medication-induced obesity: Treatment options. Obes Rev. 2004; 5: 233–238PubMedCrossRef
14.
Rubin, RR, Ma, Y, Marrero, DG, et al. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care. 2008; 31: 420–426.PubMedCrossRef
15.
Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: A patient-level meta-analysis. JAMA. 2010; 303: 47–53.PubMedCrossRef
16.
Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and Drug Administration. PLOS Med. 2008; 5(2): e045.
17.
Agency for Healthcare Research and Quality. Clinical practice guideline on the management of major depression in adults. National Guideline Clearing House, USDHHS. 2011.
18.
Dozois DJ, Bieling PJ, Patelis-Siotis I, et al. Changes in self-schema structure in cognitive therapy for major depressive disorder: A randomized clinical trial. J Consult Clin Psychol. 2009; 77: 1078–1088.PubMedCrossRef
19.
Beck AT, Dozois DJ. Cognitive therapy: Current status and future directions. Annu Rev Med. 2010; 62: 397–409.CrossRef
20.
Lustman P, Griffith L, Freedand K, Kissel S, Clouse R. Cognitive behavior therapy for depression in type 2 diabetes mellitus: A randomized controlled trial. Ann Intern Med. 1998; 129: 613–621.PubMed
21.
Penckofer S, Ferrans C, Velsor-Friedrich B, Savoy S. The psychological impact of living with diabetes: Women’s day to day experiences. Diabetes Educ. 2007; 33: 680–690.PubMedCrossRef
22.
Whittemore R, Melkus G, Grey M. Self-report of depressed mood and depression in women with type 2 diabetes. Issues Ment Health Nurs. 2004; 25: 243–260.PubMedCrossRef
23.
Chiu CJ, Wray LA, Beverly EA, Dominic OG. The role of health behaviors in mediating the relationship between depressive symptoms and glycemic control in type 2 diabetes: A structural equation modeling approach. Soc Psychiatry Psychiatr Epidemiol. 2010; 45: 67–76.PubMedCrossRef
24.
Peyrot M, Rubin R. Persistence of depressive symptoms in diabetic adults. Diabetes Care. 1999; 22: 448–452.PubMedCrossRef
25.
Katon WJ, Von Korff M, Lin EHB, et al. The Pathways study: A randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry. 2004; 61: 1042–1049.PubMedCrossRef
26.
Gonzalez JS, McCarl LA, Wexler DJ, et al. Cognitive-behavioral therapy for adherence and depression (CBT-AD) in type 2 diabetes. J Cognit Psychother Int Q. 2010; 24(4): 329–343.CrossRef
27.
Markowitz S, Gonzalez, Wilinson JL, Safren SA. Treating depression in diabetes: Emerging findings. Psychosomatics 2011; 52(1): 1–18.PubMedCrossRef
28.
Khuwaja AK, Lalani S, Dhanani R, Azam IS, Rafique G, White F. Anxiety and depression among outpatients with type 2 diabetes: A multi-centre study of prevalence and associated factors. Diabetol Metab Syndr. 2010; 2: 72.PubMedCrossRef
29.
Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Prevalence of anxiety in adults with diabetes: A systematic review. J Psychosom Res. 2002; 53(6): 1053–1060.PubMedCrossRef
30.
Lloyd, CE, Dyer, PH, Barnett, AH. Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabet Med. 2000; 17(3): 198–202.PubMedCrossRef
31.
Huang CJ, Chiu HC, Lee MH, Wang SY. Prevalence and incidence of anxiety disorders in diabetic patients: A national population-based cohort study. Gen Hosp Psychiatry. 2011; 33(1): 8–15.PubMedCrossRef
32.
Anderson RJ, Grigsby AB, Freedland KE, et al. Anxiety and poor glycemic control: A meta-analytic review of the literature. Int J Psychiatry Med. 2002; 32(3): 235–247CrossRef
33.
Pasquini M, Picardi A, Biondi M, Gaetano P, Morosini P. Relevance of anger and irritability in outpatients with major depressive disorder. Psychopathology. 2004; 37(4): 155–160.PubMedCrossRef
34.
Yi JP, Yi JC, Vitaliano PP, Weinger K. How does anger coping style affect glycemic control in diabetes patents? Int J Behav Med. 2008; 15(3): 167–172.PubMedCrossRef
35.
Wu SF, Huang YC, Liang SY, Wang TJ, Lee MC, Tung HH. Relationships among depression, anxiety, self-care behavior and diabetes education difficulties in patients with type 2 diabetes: A cross-sectional questionnaire survey. Int J Nurs Stud. 2011; 48:1376–1383PubMedCrossRef
36.
Wolfgang L, Hogan B, Rutledge T, Chawla A, Lenz J, Leung D. There is more to anger coping than “in” or “out”. Emotion. 2003; 3(1): 12–29.CrossRef
37.
Swenson SL, Rose M, Vittinghoff, E, Stewart A, Schillinger D. The influence of depressive symptoms on clinician-patient communication among patients with diabetes. Med Care. 2008; 46(3): 257–265.PubMedCrossRef
38.
Epstein RM, Duberstein PR, Feldman MD, et al. “I didn’t know what was wrong”: How people with undiagnosed depression recognize, name and explain their distress. J Gen Intern Med. 2010; 25: 954–961.PubMedCrossRef
39.
Gonzalez JS, Safren SA, Cagliero E, et al. Depression, self-care, and medication adherence in type 2 diabetes: Relationships across the full range of symptom severity. Diabetes Care. 2007; 30(9): 2222–2227.PubMedCrossRef
40.
Egede LE, Grubaugh AL, Ellis C. The effect of major depression on preventive care and quality of life among adults with diabetes. Gen Hosp Psychiatr. 2010; 32(6): 563–569.PubMedCrossRef
41.
Uden AL, Elofsson S, Andreasson A, Hillered E, Eriksson I, Brismar K. Gender differences in self-rated health, quality of life, quality of care, and metabolic control in patients with diabetes. Gend Med. 2008; 5(2): 162–180.CrossRef
42.
Ali S, Stone M, Skinner TC, Robertson N, Davies M, Khunti K. The association between depression and health-related quality of life in people with diabetes: A systematic literature review. Diabetes Metab Res Rev. 2010; 26(2): 75–89.PubMedCrossRef
43.
Grandy S, Chapman RH, Fox KM, SHIELD Study Group. Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors leading to Diabetes. Int J Clin Pract. 2008; 62: 562–568.PubMedCrossRef
44.
Kohen D, Burgess AP, Catalan J, Lant A. The role of anxiety and depression in quality of life and symptom reporting in people with diabetes mellitus. Qual Life Res. 1998; 7: 197–204.PubMedCrossRef
45.
Surwit RS, van Tilburg MA, Zucker N, et al. Stress management improves long-term glycemic control in type 2 diabetes. Diabetes Care. 2002; 25: 30–34.PubMedCrossRef
46.
Petrak F, Hautzinger M, Plack K, et al. Cognitive behavioural therapy in elderly type 2 diabetes patients with minor depression or mild major depression: Study protocol of a randomized controlled trial (MIND-DIA). BMC Geriatr. 2010; 10: 21.PubMedCrossRef
47.
Schneider KL, Pagoto SL, Handschin B, et al. Design and methods for a pilot randomized clinical trial involving exercise and behavioral activation to treat comorbid type 2 diabetes and major depressive disorder. Mental Health Phys Act. 2011; 4(1): 13–21.CrossRef
48.
Penckofer S, Byrn M, Mumby P, Ferrans C. Improving subject recruitment, retention, and participation in research through Peplau’s Theory of Interpersonal Relations. Nurs Sci Q. 2011; 24: 146–151.PubMedCrossRef
49.
Hollon S, DeRubeis RJ, Shelton RC, et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arc Gen Psychiatry. 2005; 62: 417–422.PubMedCrossRef
50.
Munoz RF, Ghosh Ippen C, Rao S, Le H-L, Dwyer EV. Manual for group cognitive behavioral therapy of major depression: A reality management approach [participant manual and instructor’s manual]. Retrieved March 12, 2012 from the University of California San Francisco/San Francisco General Hospital Latino Mental Health Research Program Website: http://​www.​medschool.​ucsf.​edu/​latino/​cbtdengl.​aspx.
51.
Muñoz RF, Ying YW, Bernal G, et al. Prevention of depression with primary care patients: A randomized controlled trial. Am J Community Psychol. 1995; 23: 199–222.PubMedCrossRef
52.
Williams VP, Williams RB. Lifeskills: 8 simple ways to build stronger relationships, communicate more clearly, improve your health, and even the health of those around you. New York, NY: Times Books/Random House; 1997.
53.
Kirby ED, Williams VP, Hocking MC, Lane JD, Williams RB. Psychosocial benefits of three formats of a standardized behavioral stress management program. Psychosom Med. 2006; 68: 816–823.PubMedCrossRef
54.
Abraham C, Michie S. A taxonomy of behavior change techniques used in interventions. Health Psychol. 2008; 27: 379–387.PubMedCrossRef
55.
Cowan MJ, Freedland KE, Burg MM, et al. Predictors of treatment response for depression and inadequate social support-the ENRICHD randomized clinical trial. Psychother Psychosom. 2008; 77(1): 27–37.PubMedCrossRef
56.
Freedland KE, Mohr DC, Davidson KW, Schwartz JE. Usual and unusual care: Existing practice control groups in randomized controlled trials of behavioral interventions. Psychosom Med. 2011; 73: 324–336.CrossRef
57.
Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977; 1(3): 385–401.CrossRef
58.
Zich JM, Attkinsson CC, Greenfield TK. Screening for depression in the primary clinics: The CES-D and the BDI. Int J Psychiatry Med. 1990; 20: 259–277.PubMedCrossRef
59.
60.
Speilberger C, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. State-trait anxiety inventory for adults. Menlo Park, CA: Mind Garden Inc.; 1977.
61.
Barnes L, Harp D, Jung W. Reliability generalization of scores on the Spieberger state-trait anxiety inventory. Educ Psychol Meas. 2002; 62(4): 603–618.CrossRef
62.
Spielberger C. State–trait anger expression inventory—2. Professional manual. Lutz: Psychological Assessment Resources; 1999.
63.
Arean PA, Alvidrez J. The prevalence of psychiatric disorders and subsyndromonal mental illness in low-income, medically ill elderly. Int J Psychiatry Med. 2001; 31: 9–24.PubMedCrossRef
64.
Aaron LA, Bradley LA, Alarcon GS, et al. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum. 1996; 39: 436–445.PubMedCrossRef
65.
Ross HE, Swinson R, Doumani S, Larkin EJ. Diagnosing comorbidity in substance abusers: A comparison of the test–retest reliability of two interviews. Am J Drug Alcohol Abuse. 1995; 21: 167–185.PubMedCrossRef
66.
Levitan RD, Blouin AG, Navarro JR, Hill J. Validity of the computerized DIS for diagnosing psychiatric inpatients. Can J Psychiatry. 1991; 36: 728–731.PubMed
67.
Blouin AG, Perez EL, Blouin JH. Computerized administration of the diagnostic interview schedule. Psychiatry Res. 1988; 23: 335–344.PubMedCrossRef
68.
Cholestech Corporation. The accuracy and reproducibility of a rapid, fingerstick method for measuring A1c certified by the NGSP. Technical brief. Hayward: Cholestech Corporation; 2002.
69.
70.
Quinn L, Poradzisz M, Ferrans C. Psychometric properties of the Quality of Life Index: Diabetes Version. Diabetes. 1999; 48 Supplement 1: A320.
71.
Ware JE, Kosinski M, Keller SD. A 12-item short-from health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care. 1996; 34: 220–233.PubMedCrossRef
72.
Ware JE, Kosinski M, Turner-Bowker DM, Gandek B. How to score version 2 of the SF-12 health survey. Lincoln RI: Quality Metric Incorporated; 2002.
73.
Ware JE, Kosinski M, Kleer SD. SF-12: How to score the SF-12 physical and mental health summary scales. 3rd edn. Lincoln: Quality Metric Incorporated; 1998.
74.
Fitzgerald JT, Davis WK, Connell CM, Hess GE, Funnell MM, Hiss RG. Development and validation of the diabetes care profile. Eval Health Prof. 1996; 19: 208–230.
75.
Fitzgerald JT, Funnell MM, Hess GE, et al. The reliability and validity of a brief diabetes knowledge test. Diabetes Care. 1998; 21: 706–710.PubMedCrossRef
76.
Pan A, Lucas M, Sun Q, et al. Increased mortality risk in women with depression and diabetes mellitus. Arch Gen Psychiatr. 2011; 68(1): 42–50.PubMedCrossRef
77.
Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Predicting response to cognitive behavioral therapy of depression in type 2 diabetes. Gen Hosp Psychiatr. 1998; 20: 302–306.PubMedCrossRef
78.
van Bastelaar KM, Pouwer F, Cuijpers P, Twisk JWR, Snoek FJ. Web-based cognitive behavioral therapy (W-CBT) for diabetes patients with co-morbid depression: Design of a randomised controlled trial. BMC Psychiatry. 2008; 8: 9 (doi:10.​1186/​1471-244X/​8/​9).PubMedCrossRef
79.
Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression and chronic illness. New Engl J Med. 2010; 363(27): 2611–2620.PubMedCrossRef
80.
Lamers F, Jonkers CCM, Bosma H, Knotternerus JA, van Elijk JThM. Treating depression in diabetes patients: Does a nurse administered minimal psychological intervention affect diabetes-specific quality of life and glycaemic control. A randomized trial. J Adv Nurs. 2011; 67(4): 788–799.PubMedCrossRef
81.
Orth-Gomer K, Schneiderman N, Wang HX, Walldin C, Blom M, Jernberg T. Stress reduction prolongs life in women with coronary disease: The Stockholm Women’s Intervention Trial for Coronary Heart Disease (SWITCHD). Circ Cardiovas Qual Outcomes. 2009; 2: 25–32.CrossRef
82.
Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003; 289: 3106–3116.PubMedCrossRef
83.
Skaff MM, Mullan JT, Hoffman L, et al. Daily negative mood affects fasting glucose in type 2 diabetes. Health Psychol. 2009; 28(3): 265–272.PubMedCrossRef
84.
Rausch JR. Measures of glycemic variability and links with psychological functioning. Curr Diabetes Rep. 2010; 10(6): 415–421.PubMedCrossRef
85.
86.
Black SJ, Everhart DE, Durham TW, Walker M, Golden J, Demaree HA. The effects of anxiety on affective learning and serial position recall. Int J Neurosci. 2008; 118: 1269–1285.PubMedCrossRef
87.
Baker JE, Shannon S. The reasoning in depression: Impairment on a concept discrimination learning task. Cognit Emot. 1995; 9: 579–597.CrossRef
88.
Brand S, Reimer T, Opwis K. How do we learn in a negative mood? Effects of a negative mood on transfer and learning. Learn Instruct. 2007; 17: 1–16.CrossRef
89.
Fredrickson BL, Branigan C. Positive emotions broaden the scope of attention and thought-action repertoires. Cognit Emot. 2005; 19: 313–332.CrossRef
90.
Huang ES, Brown SE, Ewigman BG, Foley EC, Meltzer DO. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care. 2007; 30: 2478–2483.PubMedCrossRef
91.
Egede LE, Ellis C. The effects of depression on diabetes knowledge, diabetes self-management, and perceived control in indigent patients with type 2 diabetes. Diabetes Technol Thera. 2008; 10: 213–219.CrossRef
92.
Ellis SE, Speroff T, Dittus RS, Brown A, Pichert JW, Elasy TA. Diabetes patient education: A meta-analysis and meta-regression. Patient Educ Couns. 2004; 52: 97–205.PubMedCrossRef
93.
Pibernik-Okanovic M, Ajdukovic D, Lovrencic MV, Hermanns N. Does treatment of subsydromal depression improve depression and diabetes related outcomes: Protocol for a randomized controlled comparison of psycho-education, physical exercise and treatment as usual. Trials. 2011; 12: 17.PubMedCrossRef
94.
Beverly EA, Hultgren BA, Brooks KNM, Ritholz MD, Abrahamson MJ, Weinger KW. Understanding physicians’ challenges when treating type 2 diabetic patients’ social and emotional difficulties. Diabetes Care. 2011; 34: 1086–1088.PubMedCrossRef
95.
96.
McCollum M, Hansen LB, Lu L, Sullivan PW. Gender differences in diabetes mellitus and effects on self-care activity. Gend Med. 2005; 2(4): 246–254.PubMedCrossRef
97.
Long CG, Fulton B, Hollin CR. The development of a ‘best practice’ service for women in medium-secure psychiatric setting: Treatment components and evaluation. Clin Psychol Psychother. 2008; 15: 304–319.PubMedCrossRef
98.
Gucciardi E, Wang SC, DeMelo M, Amaral L, Stewart DE. Characteristics of men and women with diabetes: Observations during patients’ initial visit to a diabetes education centre. Can Fam Physician. 2008; 54: 219–227.PubMed
99.
Kacerovsky-Bielesz G, Lienhardt S, Hagenhofer M, et al. Sex-related psychological effects on metabolic control in type 2 diabetes. Diabetologia. 2009; 52: 781–788.PubMedCrossRef
100.
Barrera M, Toobert DJ, Strycker LA, Osuna D, King D, Glasgow RE. Multiple-behavior-change interventions for women with type 2 diabetes. Diabetes Spectrum. 2011; 24: 75–80.CrossRef
Metadata
Title
A Psychoeducational Intervention (SWEEP) for Depressed Women with Diabetes
Authors
Sue M. Penckofer, Ph.D., R.N.
Carol Ferrans, Ph.D., R.N.
Patricia Mumby, Ph.D., R.N.
Mary Byrn, Ph.D., R.N.
Mary Ann Emanuele, M.D.
Patrick R. Harrison, M.A.
Ramon A. Durazo-Arvizu, Ph.D.
Patrick Lustman, Ph.D.
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Annals of Behavioral Medicine / Issue 2/2012
Print ISSN: 0883-6612
Electronic ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-012-9377-2

Other articles of this Issue 2/2012

Annals of Behavioral Medicine 2/2012 Go to the issue

Original Article

Predicting Human Papillomavirus Vaccine Uptake in Young Adult Women: Comparing the Health Belief Model and Theory of Planned Behavior

Invited Commentary

International Collaborations and Multidisciplinary Approaches in High-Quality Behavioral Medicine Research: a Comment on O’Leary et al

Invited Commentary

Contemplative Practice, Chronic Fatigue, and Telomerase Activity: a Comment on Ho et al.

Original Article

A Systematic Review of Randomized Controlled Trials on the Effectiveness of Computer-Tailored Physical Activity and Dietary Behavior Promotion Programs: an Update

Original Article

Moderation and Mediation of an Effective HIV Risk-Reduction Intervention for South African Adolescents

Original Article

The Built Environment Moderates Effects of Family-Based Childhood Obesity Treatment over 2 Years